[Psoriasis and HIV infection] (Q83009631)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19091213 AND SRC:MED&resulttype=core&format=json

18 January 2020

review article

1 reference

title

[Psoriasis and HIV infection] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19091213 AND SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Leal L

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19091213 AND SRC:MED&resulttype=core&format=json

18 January 2020

Ribera M

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19091213 AND SRC:MED&resulttype=core&format=json

18 January 2020

Daudén E

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19091213 AND SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19091213 AND SRC:MED&resulttype=core&format=json

Actas Dermo-Sifiliográficas

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19091213 AND SRC:MED&resulttype=core&format=json

18 January 2020

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19091213 AND SRC:MED&resulttype=core&format=json

18 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19091213 AND SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

753-763

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19091213 AND SRC:MED&resulttype=core&format=json

Psoriasis and human immunodeficiency virus infection

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

[HIV-associated psoriasis. Clinical and histological observations in 36 patients]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Cytokine gene polymorphisms in psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Psoriasis--recent advances in understanding its pathogenesis and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

The Effect of Tenidap on Cytokines, Acute‐Phase Proteins, and Virus Load in Human Immunodeficiency Virus (HIV)‐Infected Patients: Correlation between Plasma HIV‐1 RNA and Proinflammatory Cytokine Levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Accelerated course of human immunodeficiency virus infection after tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

A Double-Blind Placebo-Controlled Phase II Trial of Thalidomide in Asymptomatic HIV-Positive Patients: Clinical Tolerance and Effect on Activation Markers and Cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

HLA-Cw*0602 and HIV-associated psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

HLA-C and guttate psoriasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

The T4 lymphocyte in AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

HIV-associated psoriasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Rheumatic manifestations of HIV-AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

7 January 2021

Pityriasis rubra pilaris

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Pityriasis rubra pilaris and human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Papulosquamous dermatoses of AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Update on cutaneous manifestations of HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

7 January 2021

HIV-associated psoriasis

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Clinical improvement of HIV-associated psoriasis parallels a reduction of HIV viral load induced by effective antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Clinical improvement of psoriasis in an AIDS patient effectively treated with combination antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Treatment of HIV-associated eosinophilic pustular folliculitis with narrow-band UVB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

PUVA therapy is preferable to UVB phototherapy in the management of HIV-associated dermatoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Alterations in HIV expression in AIDS patients with psoriasis or pruritus treated with phototherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Efficacy and safety of oral retinoids in psoriasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

The co-occurrence of Reiter's syndrome and acquired immunodeficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Successful treatment of severe recurrent Reiter's syndrome with cyclosporine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Immunosuppressive drugs in HIV disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Use of etanercept in human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Reactivation of latent tuberculosis by TNF blockade: the role of interferon gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Use of infliximab to treat psoriatic arthritis in HIV-positive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

T-cell lymphopenia associated with infliximab and cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Efalizumab in routine use: a clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Efficacy and safety of etanercept in psoriasis/psoriatic arthritis: an updated review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Successful etanercept use in an HIV-positive patient with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Interactions of cyclosporine with antimicrobial agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Adverse effects and drug interactions of clinical importance with antiviral drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Systemic antifungal agents. Drug interactions of clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

The role of cytochrome P450 in antiretroviral drug interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0001-7310(08)74955-X

10.1016/S0001-7310(08)74955-X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19091213 AND SRC:MED&resulttype=core&format=json

18 January 2020

1 reference